Trupanion - TRUP Stock Forecast, Price & News

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

Trupanion Stock Performance

Trupanion stock traded down $6.25 during trading on Tuesday, reaching $65.26. The company had a trading volume of 354,518 shares, compared to its average volume of 449,341. Trupanion has a 52 week low of $50.81 and a 52 week high of $158.25. The firm's 50-day simple moving average is $62.86 and its 200 day simple moving average is $74.38. The firm has a market capitalization of $2.66 billion, a price-to-earnings ratio of -71.73 and a beta of 2.02. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.17.

Analyst Ratings Changes

Several analysts have commented on TRUP shares. Piper Sandler downgraded Trupanion from an "overweight" rating to a "neutral" rating and cut their target price for the company from $80.00 to $69.00 in a research note on Thursday, August 4th. Evercore ISI cut their target price on Trupanion to $85.00 in a research note on Tuesday. Canaccord Genuity Group cut their target price on Trupanion from $100.00 to $90.00 in a research note on Friday. Northland Securities cut their target price on Trupanion from $80.00 to $70.00 in a research note on Thursday, August 4th. Finally, Bank of America lowered their price target on Trupanion from $118.00 to $110.00 and set a "buy" rating on the stock in a report on Wednesday, April 20th.

Insider Buying and Selling

In related news, CEO Darryl Rawlings sold 4,000 shares of the firm's stock in a transaction on Tuesday, June 21st. The stock was sold at an average price of $53.10, for a total value of $212,400.00. Following the transaction, the chief executive officer now directly owns 865,109 shares of the company's stock, valued at approximately $45,937,287.90. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Trupanion news, President Margaret Tooth sold 1,000 shares of the firm's stock in a transaction dated Friday, May 13th. The stock was sold at an average price of $66.71, for a total transaction of $66,710.00. Following the sale, the president now directly owns 34,880 shares of the company's stock, valued at $2,326,844.80. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the firm's stock in a transaction dated Tuesday, June 21st. The shares were sold at an average price of $53.10, for a total value of $212,400.00. Following the sale, the chief executive officer now directly owns 865,109 shares in the company, valued at $45,937,287.90. The disclosure for this sale can be found here. In the last three months, insiders have sold 21,700 shares of company stock valued at $1,368,070. 6.77% of the stock is owned by company insiders.